Navigation Links
IMRISneuro: The iMRI technology of choice among the world's top ranked hospitals
Date:9/11/2008

WINNIPEG, Sept. 11 /PRNewswire-FirstCall/ - IMRIS (TSX: IM) announced today the sale of their flagship product, IMRISneuro, to one of the world's leading neuroscience centers, The Johns Hopkins Hospital in Baltimore, Maryland.

IMRISneuro is a fully integrated operating room including the IMRIS one-of-a kind, movable high field MRI. The new technology allows surgeons to safely image patients in the operating room during brain surgery, helping to rule out complications before the patient leaves the OR.

"The selection of IMRISneuro by a leading institution like Johns Hopkins is another clear indication of the value our system offers, as well as its growing acceptance as a mainstream product in neuroscience centers around the world," said David Graves, President and Chief Executive Officer of IMRIS.

About IMRIS:

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions designed to measurably improve patient outcomes. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to move in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons around the world for use in world-class neuroscience centers.

For more information, visit http://www.imris.com

About Johns Hopkins Hospital:

The Johns Hopkins Hospital has been ranked the number one hospital for 18 consecutive years in U.S. News & World Report's annual rankings of America's best hospitals. In the magazine's specialty rankings, Johns Hopkins neurology and neurosurgery have consistently ranked in the top two.


'/>"/>
SOURCE IMRIS Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Quantum light beams good for fast technology
2. New Smart Technology Makes Patient Data Collection Easier, More Efficient
3. Align Technology Executive to Present at Upcoming Financial Conferences
4. Pioneer Surgical Technology Hires Vice President of New Business Development
5. Purdue researchers develop technology to detect cancer by scanning surface veins
6. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
7. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
8. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
9. Stevens Health, Technology and Society roundtable: Sept. 19
10. Microbiotic technology developed for microinjection of zebrafish embryos
11. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...,, WASHINGTON , Nov. 7 /PRNewswire-USNewswire...r today in support of H.R. 3962, the Affordable He... the legislation later tonight. Below are the Spe...e all know, is an historic moment for our nation a...eaders of every party and political philosophy -- ...
(Date:11/7/2009)...,, HOUSTON, Nov. 7 T...ented Lisa James, Director of Health at the Family...istinguished Service today at its semi-annual poli... Service is the highest honor the AMA House of Del... http://www.newscom.com/cgi-bin/prnh/20081209/AM...
(Date:11/7/2009)...,, HOUSTON, Nov. 7 Calling this...ciation (AMA), the AMA President J. James Rohack, ...physicians from all state and medical specialty so...licy-making meeting, where health system reform wi...om.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ov...
(Date:11/7/2009)...,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -...earing, antichoice extremists are holding the enti...da. They are demanding that the bill go far beyond...been incorporated into the original bill. In an o... on early Saturday afternoon, antichoice Democrats...
(Date:11/7/2009)...,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -... House of Representatives to vote for the Stupak-E..., "The Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Li...federal law on abortion funding and conscience pro... Act (H.R. 3962)," they said. ,, The letter was...
Breaking Medicine News(10 mins):Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2
...s may fight MS, cancer and heart disease, studies ...ws) -- Caffeine, green tea and tart cherries may g...vascular troubles, respectively, new research sugg...San Diego. , Caffeine appears to help ward off mul...
...ole in the most serious healthcare settings, even ...fe care, according to research in the April issue ...anadian researchers spent nearly 300 hours observi...es. , They concluded that humour played an esse...
...08 Natural,Harmony Foods, Inc. (Pink Sheets: NHYF... at multiple upcoming shows., Show ...ional Show Dallas June 5-7 Healthy Li... Philadelphia July 20-23 Natural Products E...
...ing Concerns that Future Payment &, Coverage Pol...onoscopy Screening & Sedation...onal Coalition,for Quality Colorectal Cancer Scree...ctal cancer through educational programs,aimed at ...
...ple a day" Perhaps you should be. Adults who eat...cantly reduced risk of metabolic syndrome, a clust...chronic diseases such as diabetes and cardiovascul...ion data collected in the 1999-2004 National Healt...
...It,s common knowledge,that Americans suffer under ...Heart disease is the leading cause of death for me...staggering: one in two men and one in three,women ...ullet in preventing several cancers and,cardiovasc...
Other Medicine News:Health News:Food as Medicine? 2Health News:Food as Medicine? 3Health News:Food as Medicine? 4Health News:Humor plays an important role in healthcare even when patients are terminally ill 2Health News:Humor plays an important role in healthcare even when patients are terminally ill 3Health News:Natural Harmony Foods to Exhibit in Multiple Venues in '08 2Health News:Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care: 2Health News:Non-Profit Group Formed to Promote Safe Colorectal Cancer Screenings and Care: 3Health News:Adults who eat apples, drink apple juice have lower risk for metabolic syndrome 2Health News:Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL 2
(Date:11/6/2009)..., Nov. 6 Caraco Pharmace...aunched ketorolac tromethamine ophthalmic solution... and Drug Administration (FDA) for Sun Pharma,s Ab...Acular® opthalmic solution on the first day f...olac is therapeutically equivalent to Acular®...
(Date:11/6/2009)...IS, November 6 , - Trial ...lid for the,Treatment of Multi-Resistant Staphyloc... a speciality pharmaceutical company focused on th...esigned to overcome the significant global,problem... most advanced oral,antibacterial NXL103 (floprist...
(Date:11/5/2009)...GO, Nov. 5 Althea Technologies, I...turing services for biopharmaceutical products ann...lopment to the company,s platform of services, whi...es Matsuura, Director of Formulation Development. ...ion and analytical scientists, along with new labo...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Partnership to accelerate Trudeau Institute discoveries to patient care 8711 1Partnership to accelerate Trudeau Institute discoveries to patient care 8711 2Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 1Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 2Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 3WWII Veterans Compete in National Veterans Golden Age Games 47813 1WWII Veterans Compete in National Veterans Golden Age Games 47813 2
...NTA, Dec. 11 The Arthritis Foundation,the leading...llion,Americans living with arthritis, today annou...eters of Enbrel (R) (etanercept), will be the,nati... (R)., "The Arthritis Foundation hosts hundreds o...to prevent, control and cure arthritis, the,nation...
...CETON, N.J. and FOSTER CITY, Calif., Dec. 11 /PRNe...(NYSE: BMY ) and Gilead Sciences, Inc.,(Nasdaq: ...ze ATRIPLA(R),(efavirenz 600 mg/emtricitabine 200 ... for the treatment of virologically suppressed adu... approval by the European,Commission. If approved,...
Other Medicine Technology:Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 2Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 3Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 4Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 2Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 3Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 4Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 5Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 6Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 7Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 8
Assay Development
Custom Conjugation
Iso-Electric Determination Kit
Rabbit Anti-Goat IgG (H & L) Antibody, Colloidal Gold Conjugated, 50 OD
Medicine Products: